Here’s an article about three French doctors treating COVID-19 patients with a combination of azithromycin and zinc.
“Inspired by Previous work on the combination of hydrochloroquine and azithromycin, three doctors practicing in the Moselle in northern France have tested a new treatment on hundreds of patients. Not able to prescribe chloroquine which can only be prescribed in hospital, they prescribed to their coronavirus patients the antibiotic azithromycin along with zinc to increase its effectiveness, while patients with asthma were also prescribed Singulair (montelukast), which has anti-inflammatory properties.
“Dr. Gastaldi added that he prescribed this combination to over 200 patients. Statistically, among them he would have had at least 2 deaths and 40 hospitalizations. However, he explains that he had only two serious cases that required hospitalization and have since been discharged.
“These encouraging results are reinforced by the diversity of his clientele of all ages and some with risk factors. One of Dr. Gastaldi colleagues, Dr. Erbstein, also stressed that none of his patients required hospitalization and so far none have died.”
This article in French provides the source material used for the Gilmore Health article: